SAKAR

Sakar Healthcare Share Price

 

 

Start SIP in SAKAR

Start SIP

Performance

  • Low
  • ₹440
  • High
  • ₹480
  • 52 Week Low
  • ₹210
  • 52 Week High
  • ₹505
  • Open Price₹471
  • Previous Close₹475
  • Volume90,131
  • 50 DMA₹409.01
  • 100 DMA₹391.20
  • 200 DMA₹366.91

Investment Returns

  • Over 1 Month + 19.52%
  • Over 3 Month + 11.63%
  • Over 6 Month + 35.13%
  • Over 1 Year + 86.07%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.4
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 994
  • P/B Ratio
  • 3.3
  • Average True Range
  • 28.95
  • EPS
  • 11.34
  • Dividend Yield
  • 0
  • MACD Signal
  • 9.25
  • RSI
  • 66.38
  • MFI
  • 70.02

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹446.75
-28.1 (-5.92%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹427.16
  • 50 Day
  • ₹409.01
  • 100 Day
  • ₹391.20
  • 200 Day
  • ₹366.91

Resistance and Support

479.63 Pivot Speed
  • R3 528.17
  • R2 513.58
  • R1 494.22
  • S1 460.27
  • S2 445.68
  • S3 426.32

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 230.88 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 6% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 49 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-05 Quarterly Results & Others To consider other business matters.
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results
2025-02-08 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

52.86%
13.05%
16.59%
17.5%

About Sakar Healthcare

  • NSE Symbol
  • SAKAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sanjay S Shah
  • ISIN
  • INE732S01012

Similar Stocks to Sakar Healthcare

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹446 As on 13 February, 2026 | 16:20

The Market Cap of Sakar Healthcare is ₹994 Cr As on 13 February, 2026 | 16:20

The P/E ratio of Sakar Healthcare is 39.4 As on 13 February, 2026 | 16:20

The PB ratio of Sakar Healthcare is 3.3 As on 13 February, 2026 | 16:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23